The 2021 cancer incidence rates largely returned to pre-pandemic levels, but there was no significant rebound to compensate for the 2020 diagnostic decline.
A notable exception was breast cancer, where diagnoses of advanced-stage disease increased in 2021, suggesting some missed cases from 2020 were detected later.
The NIH study indicates that while many cancer types saw incidence rates recover, advanced cases of pancreatic cancer also showed a slight increase in diagnoses.
Overall, a complete recovery in cancer diagnosis rates was not observed, with some types still below pre-pandemic measurements, indicating ongoing challenges in cancer screening.
Collection
[
|
...
]